Diabetes and neurodegeneration in Wolfram syndrome: A multicenter study of phenotype and genotype

Diabetes Care

Volumn 34, Issue 7, 2011, Pages 1503-1510

  Rohayem, Julia ^a   Ehlers, Christian ^b   Wiedemann, Bärbel ^a   Holl, Reinhard ^c   Oexle, Konrad ^d   Kordonouri, Olga ^e   Salzano, Giuseppina ^f   Meissner, Thomas ^g   Burger, Walter ^h   Schober, Edith ⁱ   Huebner, Angela ^a   Lee Kirsch, Min Ae ^a   Herr, Mathias ^j   Menzel, Ulrike ^j   Knerr, Ina ^j   Strier, Ursula ^j   Reiners Franz, Ursula ^j   Otten, Albert ^j   Bennink, Henrik ^j   Dürr, Renate ^j   Koch, Hartmut ^j   Datz, Nicolin ^j   Adam, Dietrich ^j   Witsch, Michael ^j   Siccar, Ishani ^j   Ziegler, Ralph ^j   Engelsberger, Ilse ^j   Piatkowska, Ewa ^j   Iwaniszewska, Barbara ^j   Emberger, Werner ^j   Matic, Toni ^j   Pomahacova, Renata ^j   Skala, Pavel ^j   Kuhlmann, Beatrice ^j   more..

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b Practice of Human Genetics   (Germany)

^c UNIVERSITY OF ULM   (Germany)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e Centre for Children and Adolescents   (Germany)

^f UNIVERSITY OF MESSINA   (Italy)

^g HEINRICH HEINE UNIVERSITY   (Germany)

^h Institute Springe   (Germany)

ⁱ UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

^j NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; MEMBRANE PROTEIN; WOLFRAMIN PROTEIN;

ADOLESCENT; ARTICLE; B LYMPHOCYTE; CHILD; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; ENDOPLASMIC RETICULUM STRESS; GENE; GENE MUTATION; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KETOACIDOSIS; MAJOR CLINICAL STUDY; NERVE DEGENERATION; ONSET AGE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PREVALENCE; REMISSION; SCHOOL CHILD; WFS1 GENE; WOLFRAM SYNDROME; CLINICAL TRIAL; GENETIC ASSOCIATION; GENETICS; GENOTYPE; INFANT; METABOLISM; MULTICENTER STUDY; MUTATION; PATHOPHYSIOLOGY; PHENOTYPE;

ADOLESCENT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; GENETIC ASSOCIATION STUDIES; GENOTYPE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INFANT; MEMBRANE PROTEINS; MUTATION; NERVE DEGENERATION; PHENOTYPE; WOLFRAM SYNDROME;

EID: 80054710090     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-1937     Document Type: Article

References (25)

1. CollierDA, BarrettTG, Curtis D, et al. Linkage of Wolfram syndrome to chromosome 4p16.1 and evidence for heterogeneity. Am J Hum Genet 1996;59:855-863 (Pubitemid 26328082)
2. Strom TM, Hörtnagel K, Hofmann S, et al. Diabetes insipidus, diabetes mellitus, optic atrophy and deafness (DIDMOAD) caused by mutations in a novel gene (wolframin) coding for a predicted transmembrane protein. Hum Mol Genet 1998; 7:2021-2028 (Pubitemid 28546409)
3. Malhotra JD, Kaufman RJ. Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword? Antioxid Redox Signal 2007;9:2277-2293 (Pubitemid 350059010)
4. Lin JH, Walter P, Yen TS. Endoplasmic reticulum stress in disease pathogenesis. Annu Rev Pathol 2008;3:399-425 (Pubitemid 351488287)
5. Harding HP, Ron D. Endoplasmic reticulum stress and the development of diabetes: a review. Diabetes 2002;51(Suppl. 3): S455-S461 (Pubitemid 35403430)
6. Barrett TG, Bundey SE, Macleod AF. Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet 1995;346:1458-1463
7. Lessell S, Rosman NP. Juvenile diabetes mellitus and optic atrophy. Arch Neurol 1977;34:759-765 (Pubitemid 8262150)
8. Swift RG, Sadler DB, Swift M. Psychiatric findings in Wolfram syndrome homozygotes. Lancet 1990;336:667-669 (Pubitemid 20288873)
9. Cremers CW, Wijdeveld PG, Pinckers AJ. Juvenile diabetes mellitus, optic atrophy, hearing loss, diabetes insipidus, atonia of the urinary tract and bladder, and other abnormalities (Wolfram syndrome). A review of 88 cases from the literature with personal observations on 3 new patients. Acta Paediatr Scand Suppl 1977;264: 1-16
10. Cano A, Molines L, Valéro R, Simonin G, Paquis-Flucklinger V, Vialettes B; French Group of Wolfram Syndrome. Microvascular diabetes complications in Wolfram syndrome (diabetes insipidus, diabetes mellitus, optic atrophy, and deafness [DIDMOAD]): an age- and durationmatched comparison with common type 1 diabetes. Diabetes Care 2007;30:2327-2330 (Pubitemid 47364643)
11. Cryns K, Sivakumaran TA, Van den Ouweland JM, et al. Mutational spectrum of the WFS1 gene in Wolfram syndrome, nonsyndromic hearing impairment, diabetes mellitus, and psychiatric disease. Hum Mutat 2003;22:275-287 (Pubitemid 37210853)
12. Giuliano F, Bannwarth S, Monnot S, et al.; French Group ofWS. Wolfram syndrome in French population: characterization of novel mutations and polymorphisms in theWFS1 gene. Hum Mutat 2005;25:99-100
13. Cano A, Rouzier C, Monnot S, et al.; French Group of Wolfram Syndrome. Identification of novelmutations inWFS1 and genotype-phenotype correlation in Wolfram syndrome. Am J Med Genet A 2007;143A:1605-1612 (Pubitemid 47047786)
14. Ishihara H, Takeda S, Tamura A, et al. Disruption of the WFS1 gene in mice causes progressive beta-cell loss and impaired stimulus-secretion coupling in insulin secretion. Hum Mol Genet 2004;13: 1159-1170 (Pubitemid 38786998)
15. Kinsley BT, Swift M,Dumont RH, Swift RG. Morbidity and mortality in the Wolfram syndrome. Diabetes Care 1995;18:1566-1570
16. Fishman L, Ehrlich RM. Wolfram syndrome: report of four new cases and a review of literature. Diabetes Care 1986;9:405-408 (Pubitemid 16040611)
17. Fonseca SG, Ishigaki S, Oslowski CM, et al. Wolfram syndrome 1 gene negatively regulates ER stress signaling in rodent and human cells. J Clin Invest 2010; 120:744-755
18. Riggs AC, Bernal-Mizrachi E, Ohsugi M, et al. Mice conditionally lacking the Wolfram gene in pancreatic islet beta cells exhibit diabetes as a result of enhanced endoplasmic reticulum stress and apoptosis. Diabetologia 2005;48:2313-2321 (Pubitemid 41618923)
19. Karasik A, O'Hara C, Srikanta S, et al. Genetically programmed selective islet beta-cell loss in diabetic subjects with Wolfram's syndrome. Diabetes Care 1989; 12:135-138 (Pubitemid 19064407)
20. Robertson RP, Harmon JS. Diabetes, glucose toxicity, and oxidative stress: a case of double jeopardy for the pancreatic islet beta cell. Free Radic Biol Med 2006;41: 177-184 (Pubitemid 43928495)
21. Johnson JD, Luciani DS. Mechanisms of pancreatic beta-cell apoptosis in diabetes and its therapies. Adv Exp Med Biol 2010; 654:447-462
22. Eizirik DL, Cardozo AK, Cnop M. The role for endoplasmic reticulum stress in diabetes mellitus. Endocr Rev 2008;29: 42-61 (Pubitemid 351252746)
23. FedericiM, HribalM, Perego L, et al. High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. Diabetes 2001;50:1290-1301 (Pubitemid 32500161)
24. Lai E, Bikopoulos G, Wheeler MB, Rozakis-Adcock M, Volchuk A. Differential activation of ER stress and apoptosis in response to chronically elevated free fatty acids in pancreatic beta-cells. Am J Physiol EndocrinolMetab 2008;294:E540-E550 (Pubitemid 351355224)
25. Hofmann S, Philbrook C, Gerbitz KD, Bauer MF. Wolfram syndrome: structural and functional analyses of mutant and wild-type wolframin, the WFS1 gene product. Hum Mol Genet 2003;12:2003-2012 (Pubitemid 37038809)